|
|
||||||||
Department of Nuclear Medicine, Kanazawa University School of Medicine, Kanazawa; Division of Blood Transfusion, Kanazawa University Hospital, Kanazawa, Cardiovascular Center, Tsuruga City Hospital; Tsuruga, Japan
Correspondence: For correspondence or reprints contact: Eui-Hyo Hwang, MD, Department of Nuclear Medicine, Kanazawa University School of Medicine, 13-1 Takaramachi, Kanazawa 920-8640, Japan.
ABSTRACT
Global absence of myocardial 123I-15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (BMIPP) uptake is occasionally noted, and it reflects myocardial long-chain fatty acid uptake abnormality. CD36, a membrane glycoprotein expressed on platelet, monocyte and endothelial cells, may contribute to myocardial fatty acid transport, and its deficiency has been reported in a small subset of the population. We hypothesized that CD36 deficiency may be related to absent myocardial BMIPP uptake. Thus, we investigated CD36 expression of platelet/monocyte in patients with absent myocardial BMIPP uptake. Methods: Peripheral blood of 7 patients with global absence of myocardial BMIPP uptake (3 of 7 patients in one family) and 3 control subjects were examined in flow cytometric analysis. Platelet/monocyte surface CD36 was detected by using 0KM5, an anti-CD36 mouse monoclonal antibody. Results:There were no apparent relationships between specific clinical symptoms and absent myocardial BMIPP uptake. None of the blood samples of the 7 patients were stained with 0KM5 on the platelet/monocyte cell surface, indicating that all of these patients were Type I CD36-deficient subjects. In contrast, all the control subjects showed normal staining. Conclusion:The fact that rare Type I CD36 deficiency was observed in all patients with absent myocardial BMIPP uptake suggests that CD36 plays a role in the myocardial long-chain fatty acid uptake process in humans.
Key Words: 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid family CD36 deficiency
This article has been cited by other articles:
![]() |
M. Furuhashi, N. Ura, T. Nakata, and K. Shimamoto Insulin Sensitivity and Lipid Metabolism in Human CD36 Deficiency Diabetes Care, February 1, 2003; 26(2): 471 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kitagawa, K. Takeda, K. Saito, S. Okamoto, K. Makino, H. Maeda, and T. Ichihara Differences in Fatty Acid Metabolic Disorder Between Ischemic Myocardium and Doxorubicin-Induced Myocardial Damage: Assessment Using BMIPP Dynamic SPECT with Analysis by the Rutland Method J. Nucl. Med., October 1, 2002; 43(10): 1286 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Janabi, S. Yamashita, K.-i. Hirano, N. Sakai, H. Hiraoka, K. Matsumoto, Z. Zhang, S. Nozaki, and Y. Matsuzawa Oxidized LDL-Induced NF-{kappa}B Activation and Subsequent Expression of Proinflammatory Genes Are Defective in Monocyte-Derived Macrophages From CD36-Deficient Patients Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1953 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Febbraio, N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. A. Pearce, and R. L. Silverstein A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism J. Biol. Chem., July 2, 1999; 274(27): 19055 - 19062. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |